304
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Response to the letter regarding “Is it really safe to withhold folinic acid when less than 1000 mg/m2 methotrexate is ingested?”

, &
Page 1020 | Received 21 Mar 2017, Accepted 22 Mar 2017, Published online: 27 Apr 2017

References

  • Warren RD, Nichols AP, Bender RA. Membrane transport of methotrexate in human lymphoblastoid cells. Cancer Res. 1978;38:668–671.
  • Ogungbenro K, Aarons L, Cresim, et al. Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate. J Pharmacokinet Pharmacodyn. 2014;41:173–185.
  • Chan BS, Dawson AH, Buckley NA. What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning? Clin Toxicol (Phila). 2017;55:88–96.
  • Harvey VJ, Slevin ML, Woollard RC, et al. The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing in the chemotherapy cycle. Cancer Chemother Pharmacol. 1984;13:91–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.